License / Permit / Service Description
- Professional KKM Pharmaceutical Services Support Letter application and pharmaceutical regulatory compliance coordination services for businesses in Malaysia. We assist with reviewing the purpose of the requested support letter, identifying the relevant pharmaceutical authority, preparing application and cover letters, coordinating company, premises, product, pharmacist, and licensing documents, submission assistance, regulatory correspondence, and follow-up where applicable. Our service is suitable for community pharmacies, pharmaceutical wholesalers, medicine distributors, pharmaceutical importers, manufacturers, healthcare product suppliers, pharmaceutical warehouses, and businesses requiring pharmaceutical regulatory confirmation or supporting documentation for licensing or official purposes. We also provide administrative and compliance support for businesses coordinating pharmaceutical requirements with local authority business licensing, premises applications, product registration, wholesale activities, and other regulatory processes. Any support letter, licence, registration, or approval remains subject to the responsible authority's assessment.
Related Departments / Regulatory Bodies
- Ministry of Health Malaysia (MOH/KKM)
- Pharmaceutical Services Programme (PSP)
- Pharmaceutical Services Division, State Health Department (JKN)
- Pharmacy Enforcement Division
- National Pharmaceutical Regulatory Agency (NPRA)
- Drug Control Authority (DCA/PBKD)
- Pharmacy Board Malaysia (Lembaga Farmasi Malaysia)
- Local Authorities (PBT), where applicable
- Royal Malaysian Customs Department (JKDM), where applicable
- Companies Commission of Malaysia (SSM)
- Department of Occupational Safety and Health (DOSH/JKKP), where applicable
- Fire and Rescue Department of Malaysia (BOMBA), where applicable
- Registered pharmacists, licence holders, pharmaceutical manufacturers, importers, wholesalers, and distributors
License Name ( Bahasa Malayu )
- Permohonan Surat Sokongan Jabatan Farmasi KKM
Application Scenarios & Business Necessity
- A local authority requests a support letter or confirmation from the Pharmaceutical Services authority before processing a pharmacy-related business licence.
- A company intends to establish a new community pharmacy or pharmaceutical-related business premises.
- An existing pharmacy is relocating, renovating, expanding, or changing its business activities.
- A pharmaceutical wholesaler requires clarification concerning licensing and regulatory requirements.
- A company intends to import, distribute, or supply medicinal products in Malaysia.
- A pharmaceutical manufacturer requires supporting documentation for a specific licensing or regulatory application.
- A business needs clarification on whether its products are classified as medicinal products, cosmetics, scheduled poisons, or another regulated category.
- A company needs to identify applicable requirements involving registered pharmacists or responsible licence holders.
- A business is establishing a pharmaceutical storage or distribution facility.
- A licensing authority, landlord, project consultant, or government agency requests pharmaceutical regulatory documentation.
- A company has received a request for additional documents, regulatory clarification, or supporting information from the relevant authority.
- A business needs assistance determining whether a support letter, poisons licence, product registration, manufacturer licence, importer licence, or wholesaler licence is the appropriate regulatory requirement.
Important Rules & Compliance Standards
- The applicant must clearly identify the purpose of the requested support letter and the authority or organisation requiring it.
- All company information, premises details, pharmaceutical product information, declarations, and supporting documents must be genuine, accurate, complete, and up to date.
- Applicable pharmaceutical activities must comply with the Poisons Act 1952 (Act 366) and relevant subsidiary regulations where applicable.
- The Sale of Drugs Act 1952 (Act 368) and Control of Drugs and Cosmetics Regulations 1984 may apply to regulated medicinal products and cosmetics.
- Activities involving pharmacists must comply with applicable requirements under the Registration of Pharmacists Act 1951 (Act 371).
- Medicinal products requiring registration must obtain the appropriate registration before being marketed, unless a lawful exemption or other applicable authorisation exists.
- Pharmaceutical manufacturing, import, and wholesale activities may require separate licences under the applicable regulatory framework.
- Businesses handling scheduled poisons must obtain the relevant licences or authorisations where required.
- Premises, storage conditions, distribution practices, and handling procedures must comply with applicable regulatory requirements.
- Good Manufacturing Practice (GMP) or Good Distribution Practice (GDP) requirements may apply depending on the activity and licence category.
- Additional documents, pharmacist details, premises plans, product lists, existing licences, or technical information may be requested.
- A support letter does not replace separate product registration, licensing, inspection, or statutory compliance requirements.
- Processing time depends on the purpose, document completeness, regulatory assessment, and relevant authority's procedures.
- The issuance, wording, scope, and acceptance of a support letter remain subject to the responsible authorities.
- This service does not guarantee the issuance of a support letter, licence, registration, or approval.
Compound & Legal Penalties
- Delay, rejection, or inability to proceed with a related pharmacy business licence, premises application, or pharmaceutical regulatory submission.
- Requirement to submit additional documents, pharmacist information, product details, corrected declarations, or regulatory clarification.
- Regulatory inspections, compliance notices, investigations, or enforcement action where pharmaceutical requirements are not met.
- Enforcement action for unlawful sale, supply, possession, storage, or distribution of scheduled poisons or regulated medicinal products.
- Enforcement action involving unregistered medicinal products or unauthorised manufacturing, import, or wholesale activities.
- Possible seizure, detention, or other lawful action involving non-compliant pharmaceutical products.
- Compounds, fines, imprisonment, or prosecution for offences under applicable pharmaceutical legislation.
- Suspension, revocation, or other action affecting relevant licences where authorised by law.
- Additional costs for corrective measures, product handling, storage improvements, documentation, or regulatory compliance.
- Business interruption, reputational damage, or difficulty obtaining other licences and commercial approvals.
- Potential liability for companies, licence holders, pharmacists, and other responsible persons where offences are established.
- Failure to obtain a support letter is not automatically a criminal or regulatory offence. Penalties depend on the specific legal requirements breached.
Frequently Asked Question
A KKM Pharmaceutical Services Support Letter generally refers to official written support, confirmation, or regulatory clarification requested from the relevant Pharmaceutical Services authority for a specific pharmacy, pharmaceutical business, premises, licensing, or administrative purpose.
No. A support letter is not automatically a pharmacy-related licence, poisons licence, product registration, manufacturer licence, importer licence, or wholesaler licence. Separate authorisations may be required.
A local authority, licensing agency, project consultant, landlord, or other relevant organisation may request pharmaceutical regulatory confirmation or supporting documentation before processing a particular application.
Depending on the purpose, documents may include SSM company information, premises details, business activity descriptions, location and layout plans, product lists, pharmacist registration information, existing licences, photographs, and the letter requesting support.
No. A separate support letter is not automatically required for every pharmaceutical business. Requirements depend on the type of activity, applicable legislation, licensing conditions, and requests from the relevant authority.
It depends on the nature of the business and the regulatory matter. Certain activities involving scheduled poisons or pharmacy practice require appropriately registered and authorised pharmacists. A support letter does not replace these requirements.
Processing time depends on the purpose of the request, document completeness, regulatory assessment, additional information requirements, and procedures of the relevant authority. There is no single guaranteed processing period.
A business must satisfy all applicable licensing, product registration, pharmacist, premises, and regulatory requirements before conducting regulated activities. A pending support letter does not automatically authorise operations.
A support letter generally concerns a specific request for confirmation or regulatory support. NPRA product registration is a separate regulatory process involving the evaluation and registration of regulated products through the Drug Control Authority.
Yes. Conzlab can assist with application purpose review, document preparation, company and premises information coordination, submission assistance, regulatory correspondence, and follow-up. Any official confirmation or approval remains subject to the responsible authority.
Jeffrey Eh Hao Yih , Director
Jeffrey has been providing expert guidance for businesses dealing with ongoing challenges. With his expertise, he aids clients in strategic business planning, streamlining operations, and enhancing productivity. Additionally, Jeffrey offers diverse business technology services to help digitize traditional businesses effectively.